Journal of the American Heart Association · 2012 · 28 citations · 36 references
Increased progression of atherosclerotic cardiovascular disease in MetS and type 2 diabetes mellitus might be explained in part by an increase in the arterial retention of cholesterol-rich remnants. Furthermore, ezetimibe alone or in combination treatment with simvastatin could be beneficial in ameliorating atherosclerotic cardiovascular disease in insulin resistance and MetS.
36
Robert H. Eckel, KGMM Alberti, Scott M. Grundy et al. · The Lancet · 2010 · 6.3K citations
Yutaka Nakashima, Hiroshi Fujii, Shinji Sumiyoshi et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2007 · 428 citations · Full text